Download - Evaluation of the patient with hematuria
![Page 1: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/1.jpg)
![Page 2: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/2.jpg)
Evaluationof the patient with
Hematuria Meshari Alzahrani
Medical Intern – MBBSAUA Member
29/1/2014
![Page 3: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/3.jpg)
Introduction
TerminologyBasic ScienceGross Hematuria PseudohematuriaMicroscopic Hematuria
![Page 4: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/4.jpg)
Terminology
Haematuria : blood in the urine.– gross, or macroscopic, when there is sufficient blood
present to color the urine red or brown. – microscopic when the urine is visually normal in color
but is found to contain blood on chemical analysis or microscopic evaluation.
– asymptomatic microhematuria (AMH) is defined as: 3 or greater RBCs / HPF on a properly collected urinary
specimen in the absence of an obvious benign cause.
HPF : high power field – Normally between 0 – 3 RBCs are seem per HPF
![Page 5: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/5.jpg)
Urine microscopy showing RBCs
Gross Haematuria
![Page 6: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/6.jpg)
Basic Science
RBCs may be excreted in the urine by normal persons.
It is not known precisely how these cells reach the urinary tract.
However, the normal excretion rate is :
0.5 to 2 million RBCs/24 hr, or <5 RBCs/hpf on microscopic examination of a urine specimen.
![Page 7: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/7.jpg)
It is difficult to localize the site of bleeding by routine examination of the patient with hematuria.
However, certain findings may be very helpful depend on size & shape of RBCs. For example, casts form in
the lumina of renal tubules. Therefore, the presence of
RBCs casts localizes the site of bleeding to the renal parenchyma.
![Page 8: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/8.jpg)
Non-glomerular Glomerular* Hematuria
Uniform Irregular Size
Larger Small Shape
Peripheral Nephron Source
*The reason that make Glomerular RBCs irregular & small cause it pass through kidney chemicals & nephron that lead to change in shape & size as long as its pass through these jurney
![Page 9: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/9.jpg)
Common cause of Haematuria
Infection of the urine. Kidney and bladder stones . Trauma to the urinary tract. Bladder tumors. Prostate tumors. kidney tumors and other kidney
diseases. Blood disorders
![Page 10: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/10.jpg)
Approach to Patient with blood in urine
History takingPhysical examinationDifferential DiagnosisInvestigation, Lab , Radiology
![Page 11: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/11.jpg)
History Taking
Personal :– Gender ( female, male)– Age ( older, younger)
Chief Complaint : Blood in Urine +/- Associated symptoms
Duration : Acute , Chronic . History of presenting illness :– Onset : Sudden , Progressive , transient, persistent,
recurrent – Pattern: gross vs. microscopic, constant vs.
intermittent, glomerular vs. extraglomerular , painless vs. painful
![Page 12: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/12.jpg)
Associated symptoms : – Fever, back pain, dysuria, urgency,
frequency (UTI)– renal colic or previous nephrolithiasis
(renal stone disease)– weight loss, especially with abdominal pain
(RCC)– weight loss with a significant smoking
history, analgesic abuse, or exposure to industrial dyes (bladder carcinoma)
– Symptoms of prostatic obstruction in older men such as hesitancy and dribbling (BPE)
– recent sore throat or skin infection, edema, hypertension (glomerulonephritis)
![Page 13: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/13.jpg)
– recent back, abdominal, or urethral injury or vigorous exercise (trauma)
– history of heart murmur with recent dental or genitourinary manipulation (endocarditis)
– or a history of bleeding from other sites, a previous bleeding disorder, or family history of a bleeding disorder (systemic coagulopathy).
– Cyclic hematuria in women that is most prominent during and shortly after menstruation, suggesting endometriosis of the urinary tract.
– Sterile pyuria with hematuria, which may occur with renal tuberculosis, analgesic nephropathy and other interstitial diseases
– Loin pain-hematuria syndrome (LPHS): (rare) recurrent episodes of severe unilateral or bilateral loin (flank) pain that were accompanied by gross or microscopic hematuria, associated with use of OCPs
![Page 14: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/14.jpg)
Urine Color, pattern: – What color is your urine? – Are you taking rifampicin? Have you eaten
beetroot (Beeturia)? – Is it pure blood or mixed with urine?– Are there any clots? (lower urinary tract
source)– Does it happen all the time when you pass water?– Is it near the beginning, end or during the entire
urine stream? – Post operative , recent urological surgery ?
![Page 15: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/15.jpg)
beetroot
rifampicin
![Page 16: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/16.jpg)
Family History : A personal or family history of hematuria with:
– deafness or ocular abnormalities with hematuria (Alport's syndrome)
– hematuria with progressive chronic renal failure (ADPKD)
– (sickle Cell Anemia) lead to papillary necrosis and hematuria.
Travel History to or Endemic area of:– (Schistosoma haematobium) is a common
cause of hematuria in certain endemic areas
![Page 17: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/17.jpg)
Antibiotics Penicillins (esp. methicillin, ampicillin)
Cephalosporins
Sulfonamides
Rifampin
IsoniazidNSIDs
Indomethacin
Phenylbutazone
Fenoprofen
Naproxen
Tolmetin
Mefenamic acidDiuretics
Thiazides
Furosemide
TriamtereneMiscellaneous
Phenytoin
Cimetidine
Allopurinol
Azathioprine
Drug History : should be taken with special attention to :–Antibiotic : Rifampin ( orange urine)–analgesics (papillary necrosis)–cyclophosphamide (hemorrhagic cystitis)– anticoagulants, –drugs known to cause acute interstitial nephritis
Drugs Associated with Acute Interstitial Nephritis.
![Page 18: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/18.jpg)
Physical Examination
Vital signs should be checked with special attention to PB ( HTN with RCC & glomerulonephritis, ADPKD) and temperature (fever with UTI)Genital examination :
possible sites of bleeding around the urethral meatus in both sexes Look for Trauma “ Foley’s Catheter Removal while balloon still inflated”For male , look for : BPH, prostatic cancer, do PR For female , look for : GYN/OBS abnormalities (vaginal bleeding)
Inspection : Rash, ecchymoses, or petechiae (coagulopathy)Lens abnormalities and hearing loss (Alport's syndrome)Edema , sore throat , (glomerulonephritis)
Palpation: renal colic flank pain radiate to groin (stone) , costovertebral angle tenderness , abdominal tenderness, and abdominal masses (RCC)Auscultation : Cardiac murmurs (endocarditis)
![Page 19: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/19.jpg)
Alport syndrome : Hereditary nephritis characterized by glomerulonephritis , end stage kidney disease, and hearing loss. Alport syndrome can also affect the eyes (lenticonus). The presence of blood in the urine (hematuria) is almost always found in this condition.
![Page 20: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/20.jpg)
Differential Diagnosis of Hematuria
Acquired glomerular and tubulointerstitial renal disease– Primary– Secondary to systemic disease (pericarditis)
Hereditary renal disease– Alport's syndrome– Polycystic kidney disease
Infection (Mycobacteria and Schistosoma)
Papillary necrosis– Sickle hemoglobin– Analgesic abuse
![Page 21: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/21.jpg)
Trauma Calculi Neoplasia– Primary– Metastatic (uncommon)
Coagulopathy– Congenital– Acquired
Differential Diagnosis of Hematuria
![Page 22: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/22.jpg)
Investigation : Lab
RFT : Serum Creatinine Urinalysis with microscopic exam
– Inadequate sample (contaminated with vaginal contents)• Squamous epithelial cells >5/hpf
– Signs of renal disease• Glomerular disease
– Urine brown (Coca-Cola color)– Microscopy
» RBCs casts» Dysmorphic RBCs
– Proteinuria
• Extraglomerular disease– Clots of blood
![Page 23: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/23.jpg)
Voided urine cytology:– No longer recommended for routine Hematuria evaluation
• Cystoscopy has higher Test Sensitivity than either urine cytology or Bladder Cancer detection markers
– Protocol• Obtain three serial fresh specimens• Evaluate for transitional cell cancer
– Bladder Cancer detection markers (no evidence for benefit over standard cytology or cystoscopy)• Fluorescent in situ hybridization (FISH)• Nuclear matrix protein 22 Test• Bladder tumor antigen stat test• Urinary Bladder cancer antigen
Nephropathy or Glomerulonephritis evaluation:• Urine Protein to Creatinine Ratio• Antinuclear Antibody• ASO Titer• Serum complement (C3, C4, C50) : ↓
![Page 24: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/24.jpg)
Prostate:• Prostate Specific Antigen (PSA)
Coagulation Factors:• INR , prothrombin time (PT)• Partial Thromboplastin Time (PTT)
Miscellaneous tests:• Collect 24 hour Urine Calcium, Urine Uric
Acid Urinalysis of "Three Glass Test" :
• Glass 1: Initiation of urine stream– Hematuria in Glass 1 only suggests Urethral
source• Glass 2: Midstream urine
– Hematuria in all glasses suggests Bladder or renal
• Glass 3: Termination of urine stream– Hematuria in Glass 3 only
suggests Prostate source
![Page 25: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/25.jpg)
Investigation : Radiology
• Helical CT Urogram (preferred)• Renal US
– Defines anatomy– Signs of glomerular disease , hydronephrosis, and renal cysts– CT Urogram is usually preferred over US
• Intravenous Pyelogram– Suspected Nephrolithiasis
• Cystoscopy– Extraglomerular source of Hematuria
• MRI Urography– Indicated where CT Urogram is contraindicated (e.g.
Pregnancy, Children)– Identifies urothelial cancer, Nephrolithiasis and renal tumors
http://www.ajronline.org/doi/full/10.2214/AJR.10.4198 American Journal of Roentgenology. 2010
![Page 26: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/26.jpg)
Evaluation Protocol
General 1 2 3 4 5
![Page 27: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/27.jpg)
General Approach– Consider non-urinary source (e.g. vagina, Rectum)– Gross Hematuria should be thoroughly evaluated including
urologic intervention – Confirm adequate sample
• Microscopic Hematuria• Squamous epithelial cells >5/hpf suggests vaginal contaminant• Urine Dipstick alone is inadequate due to high false positive rate
– False positives occur with Hemoglobinuria, Myoglobinuria and alkalotic urine (pH >9)
– False negatives occur with Vitamin C Supplementation
– Indications for Urologic intervention regardless of protocols• Gross Hematuria• Anticoagulant use with AMH• Old Age with Painless Hematuria
General
1 2 3 4 5
![Page 28: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/28.jpg)
Gross hematuria
Gross hematuria is suspected because of the presence of red or brown urine.
The color change does not necessarily reflect the degree of blood loss, since as little as 1 mL of blood per liter of urine can induce a visible color change.
Gross hematuria with passage of clots almost always indicates a lower urinary tract source.
The initial step in the evaluation of patients with red urine is centrifugation of the specimen to see if the red or brown color is in the urine sediment or the urine supernatant.
![Page 29: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/29.jpg)
Approach to the patient with red or brown urine
![Page 30: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/30.jpg)
Causes of Asymptomatic Gross Hematuria by Incidence
• Acute Cystitis (23%)• Bladder Cancer (17%)• Benign Prostatic Hyperplasia (12%)• Nephrolithiasis (10%)• Benign essential Hematuria (10%)• Prostatitis (9%)• Renal cancer (6%)• Pyelonephritis (4%)• Prostate Cancer (3%)• Urethral stricture (2%)
![Page 31: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/31.jpg)
Acute renal failure — Gross hematuria
• occurring in patients with underlying glomerular disease has been associated with the development of transient acute renal failure.
• Renal biopsy shows distension of many renal tubules by intratubular red cells and tubular cell injury consistent with acute tubular necrosis
![Page 32: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/32.jpg)
Microscopic Hematuria
–Urinary tract source•Urethra or Bladder• Prostate•Ureter or Kidney
–Non-Urinary tract source• Vagina• Anus or Rectum
![Page 33: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/33.jpg)
Pseudohematuria (non-Hematuria related Red Urine)
Rifampin Myoglobinuria Hemoglobinuria Bilirubinuria Phenothiazines Porphyria
Pyridium Phenytoin Pyridium Red diaper syndrome Phenolphthalein Laxatives Foods (Beets, Blackberries, Rhubarb)
![Page 34: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/34.jpg)
Step 1:Initial evaluation of isolated Hematuria
Indications:– Urine RBC 3/HPF or more OR– Urine RBC < 3/HPF on 2 samples• Incidental Microscopic Hematuria followed
with 3 urine samples at 6 week intervals• No further evaluation if Hematuria found
only on one of 4 samples
General
1 2 3 4 5
![Page 35: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/35.jpg)
Protocol– Evaluate and treat for secondary cause
• Urinary treat infection• Exercise Hematuria (march Hematuria, e.g. distance
runners)• Menses• Genitourinary infection (STD)• Recent urologic procedure• Trauma• Hematologic causes (consider coagulopathy)
– Repeat Urinalysis with microscopy at 6 weeks following treatment• Negative: No further evaluation required unless symptomatic• Positive: Go to Step 2Gen
eral1 2 3 4 5
![Page 36: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/36.jpg)
Step 2: Evaluate for Renal cause
Indications: – Nephropathy (IgA Nephropathy, Alport Syndrome,
Benign familial Hematuria)• Proteinuria (1+ or greater on dipstick)• Serum Creatinine elevated• Dysmorphic RBCs or RBCs casts
– Suggests glomerular cause– No dysmorphic cells suggests interstitial cause
Protocol :– (if indicated above, otherwise continue to step 3)
• Serum Creatinine with calculated GFR (obtain regardless of urine sediment)
• Urine Protein to Creatinine Ratio• Nephrology ConsultationGen
eral1 2 3 4 5
![Page 37: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/37.jpg)
Step 3: Evaluate for urologic malignancy with imaging
– CT Urogram (preferred) , OR– Alternative imaging modality
• Indications– Low risk of urologic malignancy– Contrast Media Allergy– Poor Renal Function– Radiation contraindication (e.g. pregnancy )
• Modalities (less optimal)– MR Urography or MRI Abdomen and Pelvis– Renal US– Non-contrast CT Abdomen and Pelvis (Stone protocol)– Retrograde pyelogramGen
eral1 2 3 4 5
![Page 38: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/38.jpg)
The most common risk factors for urinary tract malignancy in
AMH patients Age >35 years Smoking history in which the risk correlates with the
extent of exposure Occupational exposure to chemicals or dyes (benzenes or
aromatic amines), such as printers, painters, chemical plant workers
History of gross hematuria History of chronic cystitis or irritative voiding symptoms History of pelvic irradiation History of exposure to cyclophosphamide History of a chronic indwelling foreign body History of analgesic abuse, which is also associated with
an increased incidence of carcinoma of the kidneyThe American Urological Association (AUA)
![Page 39: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/39.jpg)
Transitional cell carcinoma (TCC)
![Page 40: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/40.jpg)
A : IVPB: (CT)C: CT urography
![Page 41: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/41.jpg)
Step 4: Urologic Evaluation
– Protocol• Urology Consultation• Cystoscopy: urethra , prostate & bladder • Consider urine cytology (3 first morning
voids)
– Positive findings on cystoscopy, imaging or labs• Management per urology
–Negative evaluation• Go to step 5Gen
eral1 2 3 4 5
![Page 42: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/42.jpg)
Step 5: Surveillance following negative Hematuria evaluation
– Repeat Urinalysis annually for 2 years following initial evaluation
– Positive Urinalysis on either of the 2 rechecks• Repeat Urinalysis, imaging and cystoscopy
within 3-5 years
–Negative Urinalysis on both of the rechecks• No further testing required unless symptomatic• Risk of future urologic malignancy <1%Gen
eral1 2 3 4 5
![Page 43: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/43.jpg)
Diagnosis, Evaluation, and Follow-up of (AMH) in Adult
AUA guideline
![Page 44: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/44.jpg)
A systematic review of the literature using the MEDLINE database(search dates January 1980 – November 2011)
![Page 45: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/45.jpg)
Asymptomatic microhematuria (AMH) is defined as: 3 or greater RBCs / HPF
on a properly collected urinary specimen in the absence of an obvious benign cause.
1
![Page 46: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/46.jpg)
A positive dipstick does not define AMH, and evaluation should be based solely on findings from microscopic examination of urinary sediment and not on a dipstick reading.
A positive dipstick reading merits microscopic examination to confirm or refute the diagnosis of AMH.
Expert Opinion
![Page 47: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/47.jpg)
The assessment of the AMH patient should include a:–careful history–physical examination– laboratory examination
to rule out benign causes of AMH such as infection, menstruation, vigorous exercise, medical renal disease, viral illness, trauma, or recent urological procedures.
Clinical Principle2
![Page 48: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/48.jpg)
Once benign causes have been ruled out, the presence of AMH should prompt a urologic evaluation
Recommendation (Evidence Strength Grade C)
3
![Page 49: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/49.jpg)
At the initial evaluation, an estimate of renal function should be obtained (may include calculated eGRF, creatinine, and BUN) because intrinsic renal disease may have implications for renal related risk during the evaluation and management of patients with AMH.
Clinical Principle
4
![Page 50: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/50.jpg)
The presence of dysmorphic RBs, proteinuria, cellular casts, and/or renal insufficiency, or any other clinical indicator suspicious for renal parenchymal disease warrants concurrent nephrologic workup but does not preclude the need for urologic evaluation.Recommendation (Evidence Strength Grade C)
5
![Page 51: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/51.jpg)
Microhematuria that occurs in patients who are taking anti-coagulants requires urologic evaluation and nephrologic evaluation regardless of the type or level of anti-coagulation therapy.
Recommendation (Evidence Strength Grade C)
6
![Page 52: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/52.jpg)
For the urologic evaluation of asymptomatic microhematuria, a cystoscopy should be performed on all patients aged 35 years and older. Recommendation (Evidence Strength Grade C)
7
![Page 53: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/53.jpg)
In patients younger than age 35 years, cystoscopy may be performed at the physician's discretion.
Option (Evidence Strength Grade C)
8
![Page 54: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/54.jpg)
Regardless of age, A cystoscopy should be performed on all patients who present with risk factors for urinary tract malignancies (e.g., irritative voiding symptoms, current or past tobacco use, chemical exposures)
Clinical Principle
9
![Page 55: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/55.jpg)
The initial evaluation for AMH should include a radiologic evaluation:• Multi-phasic computed tomography (CT)• Urography (without and with intravenous (IV)
contrast)
including sufficient phases to evaluate the renal parenchyma to rule out a renal mass and an excretory phase to evaluate the urothelium of the upper tracts, is the imaging procedure of choice because it has the highest sensitivity and specificity for imaging the upper tracts.
Recommendation (Evidence Strength Grade C)10
![Page 56: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/56.jpg)
For patients with relative or absolute contraindications that preclude use of multi-phasic CT (such as renal insufficiency, contrast allergy, pregnancy):
magnetic resonance urography (MRU) (without/with IV contrast) is an acceptable alternative imaging approach
Option (Evidence Strength Grade C)
11
![Page 57: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/57.jpg)
For patients with relative or absolute contraindications that preclude use of multiphase CT (such as renal insufficiency, contrast allergy, pregnancy) where collecting system detail is deemed imperative:
(MRI) with retrograde pyelograms (RPGs) provides alternative evaluation of the entire upper tracts Expert Opinion
12
![Page 58: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/58.jpg)
For patients with relative or absolute contraindications that preclude use of multiphase CT (such as renal insufficiency, contrast allergy) and MRI (presence of metal in the body) where collecting system detail is deemed imperative:
combining non-contrast CT or renal ultrasound (US) with retrograde pyelograms (RPGs) provides alternative evaluation of the entire upper tracts.
Expert Opinion
13
![Page 59: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/59.jpg)
The use of urine cytology and urine markers (NMP22, BTA-stat, and UroVysion FISH):
is NOT recommended as a part of the routine evaluation of the AMH patient.
Recommendation (Evidence Strength Grade C)
14
![Page 60: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/60.jpg)
In patients with persistent microhematuria following a negative work up or those with other risk factors for carcinoma in situ (e.g., irritative voiding symptoms, current
or past tobacco use, chemical exposures):cytology may be useful.
Option (Evidence Strength Grade C)
15
![Page 61: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/61.jpg)
Blue light cystoscopy :should not be used in the evaluation
of patients with SMH.
(Evidence Strength Grade C)
16
![Page 62: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/62.jpg)
If a patient with a history of persistent AMH has 2 consecutive negative annual urinalyses (one per year for two years from the time of initial evaluation or beyond):
then No further urinalyses for the purpose of evaluation of AMH are necessary.
Expert Opinion
17
![Page 63: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/63.jpg)
For persistent AMH after negative urologic work up:
Yearly urinalyses should be conducted.
Recommendation (Evidence Strength Grade C)
18
![Page 64: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/64.jpg)
For persistent or recurrent AMH after initial negative urologic work-up:
Repeat evaluation within 3-5 years should be considered. Expert Opinion
19
![Page 65: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/65.jpg)
![Page 66: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/66.jpg)
References
• AUA http://www.auanet.org/education/asymptomatic-microhematuria.cfm#9
• http://www.fpnotebook.com/ • http://www.ncbi.nlm.nih.gov/books/NBK294/• smith’s General Urology , edi17• Etiology and evaluation of hematuria in
adults : Up To Date 2014
![Page 67: Evaluation of the patient with hematuria](https://reader035.vdocuments.net/reader035/viewer/2022062312/556b0de8d8b42ae47d8b4d12/html5/thumbnails/67.jpg)
Thanks
Meshari Alqoopisi
29/1/2014